Reuters

11551-11580 (out of 14429)

US, Liberia Kick Off Trial Of Ebola Drug ZMapp

U.S. and Liberian researchers have started a clinical trial to test Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an treatment that has already been tried in a handful of Ebola patients.

Pages